About the Authors

Erik Håkansson

Roles Conceptualization, Formal analysis, Investigation, Methodology, Writing – original draft

Affiliation Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden

Intissar Anan

Roles Methodology, Writing – review & editing

Affiliation Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden

Mattias Brunström

Roles Methodology, Writing – review & editing

Affiliation Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden

Karin Hellström-Ängerud

Roles Supervision, Writing – review & editing

Affiliation Department of Nursing, Umeå University, Umeå, Sweden

Per Lindqvist

Roles Funding acquisition, Investigation, Writing – review & editing

Affiliation Department of Diagnostics and Intervention, Umeå, Sweden

Björn Pilebro

Roles Conceptualization, Formal analysis, Methodology, Supervision, Writing – review & editing

Affiliation Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden

Jonas Wixner

Roles Writing – review & editing

Affiliation Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden

Krister Lindmark

Roles Conceptualization, Data curation, Funding acquisition, Methodology, Project administration, Resources, Supervision, Writing – review & editing

krister.lindmark@regionstockholm.se

Affiliation Karolinska Institute, Department of clinical sciences, Stockholm, Sweden

Competing Interests

BP has participated in advisory boards and held lectures sponsored by Alnylam, AstraZeneca, Bayer and Pfizer, been an investigator in clinical trials sponsored by Alnylam and Intellia Tx and participated in research programs sponsored by AstraZeneca. JW reports consulting agreements with Pfizer Inc, Alnylam Pharmaceuticals, Ionis Pharmaceuticals, Intellia Therapeutics, Purpose Pharma and BridgeBio Pharma. PL has disclosed with Pfizer as consulting lecturer and as member of advisory board. MB has received lecture honoraria and consultancy fees from Amarin and AstraZeneca not related to this study. EH, IA, KHÄ and KL reports no conflicts of interest. This does not alter our adherence to PLOS ONE policies on sharing data and materials.